"Let's see what happens:"-Women's experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial

PLoS One. 2022 Nov 4;17(11):e0276499. doi: 10.1371/journal.pone.0276499. eCollection 2022.

Abstract

Open-label (honestly prescribed) placebos are an ethical way to evoke placebo effects in patients. As part of a mixed-methods study, we conducted in-depth interviews with eight menopausal women who underwent and benefitted from open-label placebo treatment in a randomized-controlled trial of hot flushes. Data were analyzed using Interpretative Phenomenological Analysis. We found that the women had low expectations about the placebo treatment yet endorsed what they referred to as "hope" and openness to "see what happens". Recording hot flushes via the symptom diary was viewed as a valuable opportunity for self-examination and appraising outcomes. Receiving relief from the placebo treatment empowered women and enhanced their sense of control and agency. In summary, participants' initial openness towards placebos, their hopes to get better, monitoring symptoms closely, and taking the initiative to address symptoms were components of a positive open-label placebo experience.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Double-Blind Method
  • Female
  • Hot Flashes* / drug therapy
  • Humans
  • Menopause*

Grants and funding

The study was supported by the Foundation for the Science of the Therapeutic Encounter (F-STE) under grant number 1705-100 (recipient: YN). The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. Website of the funder: https://www.stefound.org/. It was also supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): TRR 289 Treatment Expectation—Project Number 422744262 (Recipient: YN).